Systems and methods for stimulation-related biological circuit element analysis and use

Patent metadata

Field	Value
Publication number	US-11806534-B2
Application number	US-201916279764-A
Country	US
Kind code	B2
Filing date	Feb 19, 2019
Priority date	Jul 30, 2014
Publication date	Nov 7, 2023
Grant date	Nov 7, 2023

Abstract

A computer implemented system and method facilitates a cycle of generation, sharing, and refinement of volumes related to stimulation of anatomical tissue, such as brain or spinal cord stimulation. Such volumes can include target stimulation volumes, side effect volumes, and volumes of estimated activation. A computer system and method also facilitates analysis of groups of volumes, including analysis of differences and/or commonalities between different groups of volumes.

First claim

What is claimed is:

1. A method for electrical stimulation, comprising:
grouping, into a plurality of groups, volumes of activation (VOAs) associated with stimulations of a patient population according to clinical effects;
for at least one of the groups, identifying a biological circuit element over which a threshold number of the VOAs overlie and produce a therapeutic effect;
receiving a target stimulation site associated with a biological circuit containing the biological circuit element, wherein the target stimulation site is different from a site of an implanted lead; and
based on the identification of the biological circuit element, identifying and outputting stimulation programming parameters to stimulate the target stimulation site from the site of the implanted lead along the biologic circuit containing the biological circuit element.

2. The method of claim 1 , wherein the biological circuit element comprises a neurological fiber.

3. The method of claim 1 , wherein grouping the VOAs comprises forming a first group of the VOAs associated with a side effect, the method further comprising outputting another biological circuit element over which the threshold number of the VOAs of the first group of the VOAs overlie as a biological circuit element to avoid.

4. The method of claim 3 , further comprising generating a side effect volume based on those VOAs that overlie the other biological circuit element and produce a side effect.

5. The method of claim 1 , wherein grouping the VOAs comprises forming a first group of the VOAs associated with the therapeutic effect, the method further comprising outputting the biological circuit element over which the threshold number of the VOAs of the first group of the VOAs overlie as a biological circuit element to target.

6. The method of claim 1 , further comprising generating a target volume based on those VOAs that overlie the biological circuit element and produce the therapeutic effect.

7. The method of claim 1 , further comprising
receiving a target implant site associated with a biological circuit containing the biological circuit element and
based on the identification of the biological circuit element, identifying and outputting at least one alternative target site along the biologic circuit containing the biological circuit element.

8. The method of claim 7 , further comprising stimulating the at least one alternative target site using the stimulation programming parameters.

9. A system, comprising:
a memory device having program instructions stored thereon; and
a processor coupled to a display screen and configured for executing the program instructions, wherein the program instructions comprise:
grouping, into a plurality of groups, volumes of activation (VOAs) associated with stimulations of a patient population according to clinical effects;
for at least one of the groups, identifying a biological circuit element over which a threshold number of the VOAs overlie and produce a therapeutic effect;
receiving a target stimulation site associated with a biological circuit containing the biological circuit element, wherein the target stimulation site is different from a site of an implanted lead; and
based on the identification of the biological circuit element, identifying and outputting stimulation programming parameters to stimulate the target stimulation site from the site of the implanted lead along the biologic circuit containing the biological circuit element.

10. The system of claim 9 , wherein the biological circuit element comprises a neurological fiber.

11. The system of claim 9 , wherein grouping the VOAs comprises forming a first group of the VOAs associated with a side effect, the instructions further comprising outputting another biological circuit element over which the threshold number of the VOAs of the first group of the VOAs overlie as a biological circuit element to avoid.

12. The system of claim 11 , wherein program instructions further comprise generating a side effect volume based on those VOAs that overlie the other biological circuit element and produce a side effect.

13. The system of claim 9 , wherein grouping the VOAs comprises forming a first group of the VOAs associated with the therapeutic effect, the instructions further comprising outputting the biological circuit element over which the threshold number of the VOAs of the first group of the VOAs overlie as a biological circuit element to target.

14. The system of claim 9 , the program instructions further comprise generating a target volume based on those VOAs that overlie the biological circuit element and produce the therapeutic effect.

15. The system of claim 9 , wherein the program instructions further comprise
receiving a target implant site associated with a biological circuit containing the biological circuit element and
based on the identification of the biological circuit element, identifying and outputting at least one alternative target site along the biologic circuit containing the biological circuit element.

16. A non-transitory computer readable medium having instructions stored thereon, the instructions comprising:
grouping, into a plurality of groups, volumes of activation (VOAs) associated with stimulations of a patient population according to clinical effects;
for at least one of the groups, identifying a biological circuit element over which a threshold number of the VOAs overlie and produce a particular therapeutic effect; and
receiving a target stimulation site associated with a biological circuit containing the biological circuit element, wherein the target stimulation site is different from a site of an implanted lead; and
based on the identification of the biological circuit element, identifying and outputting stimulation programming parameters to stimulate the target stimulation site from the site of the implanted lead along the biologic circuit containing the biological circuit element.

17. The non-transitory computer readable medium having of claim 16 , the instructions further comprise generating a target volume based on those VOAs that overlie the biological circuit element and produce the therapeutic effect.

18. The non-transitory computer readable medium having of claim 16 , wherein instructions further comprise
receiving a target implant site associated with a biological circuit containing the biological circuit element and
based on the identification of the biological circuit element, identifying and outputting at least one alternative target site along the biologic circuit containing the biological circuit element.

19. The non-transitory computer readable medium having of claim 16 , wherein grouping the VOAs comprises forming a first group of the VOAs associated with a side effect, the instructions further comprising outputting another biological circuit element over which the threshold number of the VOAs of the first group of the VOAs overlie as a biological circuit element to avoid.

20. The non-transitory computer readable medium having of claim 16 , wherein grouping the VOAs comprises forming a first group of the VOAs associated with the therapeutic effect, the instructions further comprising providing an outputting the biological circuit element over which the threshold number of the VOAs of the first group of the VOAs overlie as a biological circuit element to target.

Assignees

• Boston Scient Neuromodulation Corp

Inventors

• Carcieri Stephen
• Steinke G Karl
• Yoo Peter J
• Mustakos Richard
• Bokil Hemant

Classifications

• A61N1/36128 Primary

  Control systems · CPC title

• A61N1/36185

  Selection of the electrode configuration · CPC title

• A61N1/37247 Primary

  User interfaces, e.g. input or presentation means · CPC title

• G16H30/40

  for processing medical images, e.g. editing · CPC title

• G16H50/20

  for computer-aided diagnosis, e.g. based on medical expert systems · CPC title